Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April Slee

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Clinical Lipidology|April 9, 2018
Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trialPeter P Toth, Steven R Jones, April Slee, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 20, 2023
Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas TrialSanjeev Saksena, April Slee, Andrea Natale, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS ProgramDavid R Matthews, Carol Wysham, Melanie Davies, et al.
American Heart Journal|April 23, 2005
Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM studyAnne B Curtis, A Allen Seals, Robert E Safford, et al.
The Annals of Thoracic Surgery|February 11, 2017
Oral Triiodothyronine for Infants and Children Undergoing Cardiopulmonary BypassEva M Marwali, Cindy E Boom, Novik Budiwardhana, et al.
Journal of the American College of Cardiology|October 29, 2011
Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analysesSanjeev Saksena, April Slee, Albert L Waldo, et al.
Journal of the American College of Cardiology|August 27, 2013
Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes)John J Albers, April Slee, Kevin D O'Brien, et al.
Pediatrics|May 4, 2019
Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled TrialMichael A Portman, Nagib S Dahdah, April Slee, et al.
Pediatric Cardiology|December 1, 2021
Indonesian Study: Triiodothyronine for Infants Less than 5 Months Undergoing Cardiopulmonary BypassEva Miranda Marwali, Albert Lopolisa, Alvin A Sani, et al.
Heart Rhythm|April 27, 2005
Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experienceD George Wyse, April Slee, Andrew E Epstein, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Clinical Lipidology|April 9, 2018
Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trialPeter P Toth, Steven R Jones, April Slee, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 20, 2023
Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas TrialSanjeev Saksena, April Slee, Andrea Natale, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS ProgramDavid R Matthews, Carol Wysham, Melanie Davies, et al.
American Heart Journal|April 23, 2005
Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM studyAnne B Curtis, A Allen Seals, Robert E Safford, et al.
The Annals of Thoracic Surgery|February 11, 2017
Oral Triiodothyronine for Infants and Children Undergoing Cardiopulmonary BypassEva M Marwali, Cindy E Boom, Novik Budiwardhana, et al.
Journal of the American College of Cardiology|October 29, 2011
Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analysesSanjeev Saksena, April Slee, Albert L Waldo, et al.
Journal of the American College of Cardiology|August 27, 2013
Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes)John J Albers, April Slee, Kevin D O'Brien, et al.
Pediatrics|May 4, 2019
Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled TrialMichael A Portman, Nagib S Dahdah, April Slee, et al.
Pediatric Cardiology|December 1, 2021
Indonesian Study: Triiodothyronine for Infants Less than 5 Months Undergoing Cardiopulmonary BypassEva Miranda Marwali, Albert Lopolisa, Alvin A Sani, et al.
Heart Rhythm|April 27, 2005
Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experienceD George Wyse, April Slee, Andrew E Epstein, et al.
Pageof 6